Corline Biomedical AB Logo

Corline Biomedical AB

Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.

CLBIO | ST

Overview

Corporate Details

ISIN(s):
SE0006887451
LEI:
549300KYLOA3DVEPZ069
Country:
Sweden
Address:
Lefflersgatan 5, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Corline Biomedical AB is a life-science company that develops, manufactures, and markets proprietary heparin-based solutions. It specializes in antithrombotic and anti-inflammatory surface coatings for the medical device industry and applications in regenerative medicine. The company's core offering is the Corline Heparin Surface (CHS™), a unique macro-molecular heparin technology designed to improve the biocompatibility of medical devices and manage immune responses. Its product portfolio also includes drug candidates Renaparin® and Cytoparin™, which are being developed to improve outcomes in kidney transplantation and cell therapies. Corline's technology aims to address unmet clinical needs by making foreign materials and therapeutic cells better tolerated by the patient's body.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Corline Biomedical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Corline Biomedical AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Corline Biomedical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland NOVN
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea 229500
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom NFX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan 4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland OBSN
ODI Pharma AB Logo
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
Sweden ODI
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea 226950
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France ALONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.